ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Leuprorelin Acetate Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-14O3682
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Leuprorelin Acetate Market Insights Forecast to 2028
BUY CHAPTERS

Global Leuprorelin Acetate Market Insights, Forecast to 2030

Code: QYRE-Auto-14O3682
Report
December 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Takeda
MediGene AG
Livzon Pharmaceutical Group
Bejing Biote Pharmaceutical

Leuprorelin Acetate Market

Leuprolide acetate is a synthetic nine - peptide analogue of gonadotropin - releasing hormone. Leuprolide acetate is also known as Leuprolide, is a manufactured version of a hormone used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids, and early puberty. It is given by injection into a muscle or under the skin.It is used to treat hormone-reactive cancers, such as prostate and breast cancer.It can also be used for estrogen-dependent conditions, such as endometriosis or uterine fibroids.
The global Leuprorelin Acetate market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Leuprorelin Acetate is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Leuprorelin Acetate is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Leuprorelin Acetate is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Leuprorelin Acetate include Merck, Takeda, MediGene, Livzon Pharmaceutical Group and Bejing Biote Pharmaceutical, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Leuprorelin Acetate, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Leuprorelin Acetate, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Leuprorelin Acetate, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Leuprorelin Acetate sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Leuprorelin Acetate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Leuprorelin Acetate sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Leuprorelin Acetate Market Report

Report Metric Details
Report Name Leuprorelin Acetate Market
Segment by Type
  • 1.88 mg Preparation
  • 2.75 mg Preparation
  • 3.75 mg Preparation
Segment by Application
  • Hospital
  • Clinic
  • Others
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company MediGene, Livzon Pharmaceutical Group, Bejing Biote Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Leuprorelin Acetate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Leuprorelin Acetate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Leuprorelin Acetate sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Leuprorelin Acetate Market report?

Ans: The main players in the Leuprorelin Acetate Market are MediGene, Livzon Pharmaceutical Group, Bejing Biote Pharmaceutical

What are the Application segmentation covered in the Leuprorelin Acetate Market report?

Ans: The Applications covered in the Leuprorelin Acetate Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Leuprorelin Acetate Market report?

Ans: The Types covered in the Leuprorelin Acetate Market report are 1.88 mg Preparation, 2.75 mg Preparation, 3.75 mg Preparation

Recommended Reports

GnRH Analogues

Oncology Adjuncts

Hormone Therapies

1 Study Coverage
1.1 Leuprorelin Acetate Product Introduction
1.2 Market by Type
1.2.1 Global Leuprorelin Acetate Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 1.88 mg Preparation
1.2.3 2.75 mg Preparation
1.2.4 3.75 mg Preparation
1.3 Market by Application
1.3.1 Global Leuprorelin Acetate Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Leuprorelin Acetate Sales Estimates and Forecasts 2019-2030
2.2 Global Leuprorelin Acetate Revenue by Region
2.2.1 Global Leuprorelin Acetate Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Leuprorelin Acetate Revenue by Region (2019-2024)
2.2.3 Global Leuprorelin Acetate Revenue by Region (2025-2030)
2.2.4 Global Leuprorelin Acetate Revenue Market Share by Region (2019-2030)
2.3 Global Leuprorelin Acetate Sales Estimates and Forecasts 2019-2030
2.4 Global Leuprorelin Acetate Sales by Region
2.4.1 Global Leuprorelin Acetate Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Leuprorelin Acetate Sales by Region (2019-2024)
2.4.3 Global Leuprorelin Acetate Sales by Region (2025-2030)
2.4.4 Global Leuprorelin Acetate Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Leuprorelin Acetate Sales by Manufacturers
3.1.1 Global Leuprorelin Acetate Sales by Manufacturers (2019-2024)
3.1.2 Global Leuprorelin Acetate Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Leuprorelin Acetate in 2023
3.2 Global Leuprorelin Acetate Revenue by Manufacturers
3.2.1 Global Leuprorelin Acetate Revenue by Manufacturers (2019-2024)
3.2.2 Global Leuprorelin Acetate Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Leuprorelin Acetate Revenue in 2023
3.3 Global Key Players of Leuprorelin Acetate, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Leuprorelin Acetate Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Leuprorelin Acetate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Leuprorelin Acetate, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Leuprorelin Acetate, Product Offered and Application
3.8 Global Key Manufacturers of Leuprorelin Acetate, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Leuprorelin Acetate Sales by Type
4.1.1 Global Leuprorelin Acetate Historical Sales by Type (2019-2024)
4.1.2 Global Leuprorelin Acetate Forecasted Sales by Type (2025-2030)
4.1.3 Global Leuprorelin Acetate Sales Market Share by Type (2019-2030)
4.2 Global Leuprorelin Acetate Revenue by Type
4.2.1 Global Leuprorelin Acetate Historical Revenue by Type (2019-2024)
4.2.2 Global Leuprorelin Acetate Forecasted Revenue by Type (2025-2030)
4.2.3 Global Leuprorelin Acetate Revenue Market Share by Type (2019-2030)
4.3 Global Leuprorelin Acetate Price by Type
4.3.1 Global Leuprorelin Acetate Price by Type (2019-2024)
4.3.2 Global Leuprorelin Acetate Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Leuprorelin Acetate Sales by Application
5.1.1 Global Leuprorelin Acetate Historical Sales by Application (2019-2024)
5.1.2 Global Leuprorelin Acetate Forecasted Sales by Application (2025-2030)
5.1.3 Global Leuprorelin Acetate Sales Market Share by Application (2019-2030)
5.2 Global Leuprorelin Acetate Revenue by Application
5.2.1 Global Leuprorelin Acetate Historical Revenue by Application (2019-2024)
5.2.2 Global Leuprorelin Acetate Forecasted Revenue by Application (2025-2030)
5.2.3 Global Leuprorelin Acetate Revenue Market Share by Application (2019-2030)
5.3 Global Leuprorelin Acetate Price by Application
5.3.1 Global Leuprorelin Acetate Price by Application (2019-2024)
5.3.2 Global Leuprorelin Acetate Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Leuprorelin Acetate Market Size by Type
6.1.1 US & Canada Leuprorelin Acetate Sales by Type (2019-2030)
6.1.2 US & Canada Leuprorelin Acetate Revenue by Type (2019-2030)
6.2 US & Canada Leuprorelin Acetate Market Size by Application
6.2.1 US & Canada Leuprorelin Acetate Sales by Application (2019-2030)
6.2.2 US & Canada Leuprorelin Acetate Revenue by Application (2019-2030)
6.3 US & Canada Leuprorelin Acetate Market Size by Country
6.3.1 US & Canada Leuprorelin Acetate Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Leuprorelin Acetate Sales by Country (2019-2030)
6.3.3 US & Canada Leuprorelin Acetate Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Leuprorelin Acetate Market Size by Type
7.1.1 Europe Leuprorelin Acetate Sales by Type (2019-2030)
7.1.2 Europe Leuprorelin Acetate Revenue by Type (2019-2030)
7.2 Europe Leuprorelin Acetate Market Size by Application
7.2.1 Europe Leuprorelin Acetate Sales by Application (2019-2030)
7.2.2 Europe Leuprorelin Acetate Revenue by Application (2019-2030)
7.3 Europe Leuprorelin Acetate Market Size by Country
7.3.1 Europe Leuprorelin Acetate Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Leuprorelin Acetate Sales by Country (2019-2030)
7.3.3 Europe Leuprorelin Acetate Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Leuprorelin Acetate Market Size
8.1.1 China Leuprorelin Acetate Sales (2019-2030)
8.1.2 China Leuprorelin Acetate Revenue (2019-2030)
8.2 China Leuprorelin Acetate Market Size by Application
8.2.1 China Leuprorelin Acetate Sales by Application (2019-2030)
8.2.2 China Leuprorelin Acetate Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Leuprorelin Acetate Market Size by Type
9.1.1 Asia Leuprorelin Acetate Sales by Type (2019-2030)
9.1.2 Asia Leuprorelin Acetate Revenue by Type (2019-2030)
9.2 Asia Leuprorelin Acetate Market Size by Application
9.2.1 Asia Leuprorelin Acetate Sales by Application (2019-2030)
9.2.2 Asia Leuprorelin Acetate Revenue by Application (2019-2030)
9.3 Asia Leuprorelin Acetate Sales by Region
9.3.1 Asia Leuprorelin Acetate Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Leuprorelin Acetate Revenue by Region (2019-2030)
9.3.3 Asia Leuprorelin Acetate Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Leuprorelin Acetate Market Size by Type
10.1.1 Middle East, Africa and Latin America Leuprorelin Acetate Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Leuprorelin Acetate Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Leuprorelin Acetate Market Size by Application
10.2.1 Middle East, Africa and Latin America Leuprorelin Acetate Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Leuprorelin Acetate Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Leuprorelin Acetate Sales by Country
10.3.1 Middle East, Africa and Latin America Leuprorelin Acetate Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Leuprorelin Acetate Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Leuprorelin Acetate Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Leuprorelin Acetate Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Merck Leuprorelin Acetate Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Takeda
11.2.1 Takeda Company Information
11.2.2 Takeda Overview
11.2.3 Takeda Leuprorelin Acetate Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Takeda Leuprorelin Acetate Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Takeda Recent Developments
11.3 MediGene
11.3.1 MediGene Company Information
11.3.2 MediGene Overview
11.3.3 MediGene Leuprorelin Acetate Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 MediGene Leuprorelin Acetate Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 MediGene Recent Developments
11.4 Livzon Pharmaceutical Group
11.4.1 Livzon Pharmaceutical Group Company Information
11.4.2 Livzon Pharmaceutical Group Overview
11.4.3 Livzon Pharmaceutical Group Leuprorelin Acetate Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Livzon Pharmaceutical Group Leuprorelin Acetate Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Livzon Pharmaceutical Group Recent Developments
11.5 Bejing Biote Pharmaceutical
11.5.1 Bejing Biote Pharmaceutical Company Information
11.5.2 Bejing Biote Pharmaceutical Overview
11.5.3 Bejing Biote Pharmaceutical Leuprorelin Acetate Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Bejing Biote Pharmaceutical Leuprorelin Acetate Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bejing Biote Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Leuprorelin Acetate Industry Chain Analysis
12.2 Leuprorelin Acetate Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Leuprorelin Acetate Production Mode & Process
12.4 Leuprorelin Acetate Sales and Marketing
12.4.1 Leuprorelin Acetate Sales Channels
12.4.2 Leuprorelin Acetate Distributors
12.5 Leuprorelin Acetate Customers
13 Market Dynamics
13.1 Leuprorelin Acetate Industry Trends
13.2 Leuprorelin Acetate Market Drivers
13.3 Leuprorelin Acetate Market Challenges
13.4 Leuprorelin Acetate Market Restraints
14 Key Findings in The Global Leuprorelin Acetate Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Merck
Takeda
MediGene AG
Livzon Pharmaceutical Group
Bejing Biote Pharmaceutical
List of Tables
    Table 1. Global Leuprorelin Acetate Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of 1.88 mg Preparation
    Table 3. Major Manufacturers of 2.75 mg Preparation
    Table 4. Major Manufacturers of 3.75 mg Preparation
    Table 5. Global Leuprorelin Acetate Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Leuprorelin Acetate Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Leuprorelin Acetate Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Leuprorelin Acetate Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Leuprorelin Acetate Revenue Market Share by Region (2019-2024)
    Table 10. Global Leuprorelin Acetate Revenue Market Share by Region (2025-2030)
    Table 11. Global Leuprorelin Acetate Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Leuprorelin Acetate Sales by Region (2019-2024) & (K Units)
    Table 13. Global Leuprorelin Acetate Sales by Region (2025-2030) & (K Units)
    Table 14. Global Leuprorelin Acetate Sales Market Share by Region (2019-2024)
    Table 15. Global Leuprorelin Acetate Sales Market Share by Region (2025-2030)
    Table 16. Global Leuprorelin Acetate Sales by Manufacturers (2019-2024) & (K Units)
    Table 17. Global Leuprorelin Acetate Sales Share by Manufacturers (2019-2024)
    Table 18. Global Leuprorelin Acetate Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Leuprorelin Acetate Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Leuprorelin Acetate, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Leuprorelin Acetate Price by Manufacturers 2019-2024 (USD/Unit)
    Table 22. Global Leuprorelin Acetate Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Leuprorelin Acetate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leuprorelin Acetate as of 2023)
    Table 24. Global Key Manufacturers of Leuprorelin Acetate, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Leuprorelin Acetate, Product Offered and Application
    Table 26. Global Key Manufacturers of Leuprorelin Acetate, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Leuprorelin Acetate Sales by Type (2019-2024) & (K Units)
    Table 29. Global Leuprorelin Acetate Sales by Type (2025-2030) & (K Units)
    Table 30. Global Leuprorelin Acetate Sales Share by Type (2019-2024)
    Table 31. Global Leuprorelin Acetate Sales Share by Type (2025-2030)
    Table 32. Global Leuprorelin Acetate Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global Leuprorelin Acetate Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global Leuprorelin Acetate Revenue Share by Type (2019-2024)
    Table 35. Global Leuprorelin Acetate Revenue Share by Type (2025-2030)
    Table 36. Leuprorelin Acetate Price by Type (2019-2024) & (USD/Unit)
    Table 37. Global Leuprorelin Acetate Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 38. Global Leuprorelin Acetate Sales by Application (2019-2024) & (K Units)
    Table 39. Global Leuprorelin Acetate Sales by Application (2025-2030) & (K Units)
    Table 40. Global Leuprorelin Acetate Sales Share by Application (2019-2024)
    Table 41. Global Leuprorelin Acetate Sales Share by Application (2025-2030)
    Table 42. Global Leuprorelin Acetate Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Leuprorelin Acetate Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Leuprorelin Acetate Revenue Share by Application (2019-2024)
    Table 45. Global Leuprorelin Acetate Revenue Share by Application (2025-2030)
    Table 46. Leuprorelin Acetate Price by Application (2019-2024) & (USD/Unit)
    Table 47. Global Leuprorelin Acetate Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 48. US & Canada Leuprorelin Acetate Sales by Type (2019-2024) & (K Units)
    Table 49. US & Canada Leuprorelin Acetate Sales by Type (2025-2030) & (K Units)
    Table 50. US & Canada Leuprorelin Acetate Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada Leuprorelin Acetate Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada Leuprorelin Acetate Sales by Application (2019-2024) & (K Units)
    Table 53. US & Canada Leuprorelin Acetate Sales by Application (2025-2030) & (K Units)
    Table 54. US & Canada Leuprorelin Acetate Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Leuprorelin Acetate Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Leuprorelin Acetate Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Leuprorelin Acetate Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Leuprorelin Acetate Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Leuprorelin Acetate Sales by Country (2019-2024) & (K Units)
    Table 60. US & Canada Leuprorelin Acetate Sales by Country (2025-2030) & (K Units)
    Table 61. Europe Leuprorelin Acetate Sales by Type (2019-2024) & (K Units)
    Table 62. Europe Leuprorelin Acetate Sales by Type (2025-2030) & (K Units)
    Table 63. Europe Leuprorelin Acetate Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe Leuprorelin Acetate Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe Leuprorelin Acetate Sales by Application (2019-2024) & (K Units)
    Table 66. Europe Leuprorelin Acetate Sales by Application (2025-2030) & (K Units)
    Table 67. Europe Leuprorelin Acetate Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Leuprorelin Acetate Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Leuprorelin Acetate Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Leuprorelin Acetate Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Leuprorelin Acetate Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Leuprorelin Acetate Sales by Country (2019-2024) & (K Units)
    Table 73. Europe Leuprorelin Acetate Sales by Country (2025-2030) & (K Units)
    Table 74. China Leuprorelin Acetate Sales by Type (2019-2024) & (K Units)
    Table 75. China Leuprorelin Acetate Sales by Type (2025-2030) & (K Units)
    Table 76. China Leuprorelin Acetate Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China Leuprorelin Acetate Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China Leuprorelin Acetate Sales by Application (2019-2024) & (K Units)
    Table 79. China Leuprorelin Acetate Sales by Application (2025-2030) & (K Units)
    Table 80. China Leuprorelin Acetate Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Leuprorelin Acetate Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Leuprorelin Acetate Sales by Type (2019-2024) & (K Units)
    Table 83. Asia Leuprorelin Acetate Sales by Type (2025-2030) & (K Units)
    Table 84. Asia Leuprorelin Acetate Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia Leuprorelin Acetate Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia Leuprorelin Acetate Sales by Application (2019-2024) & (K Units)
    Table 87. Asia Leuprorelin Acetate Sales by Application (2025-2030) & (K Units)
    Table 88. Asia Leuprorelin Acetate Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Leuprorelin Acetate Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Leuprorelin Acetate Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Leuprorelin Acetate Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Leuprorelin Acetate Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Leuprorelin Acetate Sales by Region (2019-2024) & (K Units)
    Table 94. Asia Leuprorelin Acetate Sales by Region (2025-2030) & (K Units)
    Table 95. Middle East, Africa and Latin America Leuprorelin Acetate Sales by Type (2019-2024) & (K Units)
    Table 96. Middle East, Africa and Latin America Leuprorelin Acetate Sales by Type (2025-2030) & (K Units)
    Table 97. Middle East, Africa and Latin America Leuprorelin Acetate Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Leuprorelin Acetate Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Leuprorelin Acetate Sales by Application (2019-2024) & (K Units)
    Table 100. Middle East, Africa and Latin America Leuprorelin Acetate Sales by Application (2025-2030) & (K Units)
    Table 101. Middle East, Africa and Latin America Leuprorelin Acetate Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Leuprorelin Acetate Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Leuprorelin Acetate Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Leuprorelin Acetate Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Leuprorelin Acetate Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Leuprorelin Acetate Sales by Country (2019-2024) & (K Units)
    Table 107. Middle East, Africa and Latin America Leuprorelin Acetate Sales by Country (2025-2030) & (K Units)
    Table 108. Merck Company Information
    Table 109. Merck Description and Major Businesses
    Table 110. Merck Leuprorelin Acetate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 111. Merck Leuprorelin Acetate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Merck Recent Developments
    Table 113. Takeda Company Information
    Table 114. Takeda Description and Major Businesses
    Table 115. Takeda Leuprorelin Acetate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 116. Takeda Leuprorelin Acetate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Takeda Recent Developments
    Table 118. MediGene Company Information
    Table 119. MediGene Description and Major Businesses
    Table 120. MediGene Leuprorelin Acetate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 121. MediGene Leuprorelin Acetate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. MediGene Recent Developments
    Table 123. Livzon Pharmaceutical Group Company Information
    Table 124. Livzon Pharmaceutical Group Description and Major Businesses
    Table 125. Livzon Pharmaceutical Group Leuprorelin Acetate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 126. Livzon Pharmaceutical Group Leuprorelin Acetate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Livzon Pharmaceutical Group Recent Developments
    Table 128. Bejing Biote Pharmaceutical Company Information
    Table 129. Bejing Biote Pharmaceutical Description and Major Businesses
    Table 130. Bejing Biote Pharmaceutical Leuprorelin Acetate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 131. Bejing Biote Pharmaceutical Leuprorelin Acetate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Bejing Biote Pharmaceutical Recent Developments
    Table 133. Key Raw Materials Lists
    Table 134. Raw Materials Key Suppliers Lists
    Table 135. Leuprorelin Acetate Distributors List
    Table 136. Leuprorelin Acetate Customers List
    Table 137. Leuprorelin Acetate Market Trends
    Table 138. Leuprorelin Acetate Market Drivers
    Table 139. Leuprorelin Acetate Market Challenges
    Table 140. Leuprorelin Acetate Market Restraints
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Leuprorelin Acetate Product Picture
    Figure 2. Global Leuprorelin Acetate Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Leuprorelin Acetate Market Share by Type in 2023 & 2030
    Figure 4. 1.88 mg Preparation Product Picture
    Figure 5. 2.75 mg Preparation Product Picture
    Figure 6. 3.75 mg Preparation Product Picture
    Figure 7. Global Leuprorelin Acetate Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Leuprorelin Acetate Market Share by Application in 2023 & 2030
    Figure 9. Hospital
    Figure 10. Clinic
    Figure 11. Others
    Figure 12. Leuprorelin Acetate Report Years Considered
    Figure 13. Global Leuprorelin Acetate Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Leuprorelin Acetate Revenue 2019-2030 (US$ Million)
    Figure 15. Global Leuprorelin Acetate Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Leuprorelin Acetate Revenue Market Share by Region (2019-2030)
    Figure 17. Global Leuprorelin Acetate Sales 2019-2030 ((K Units)
    Figure 18. Global Leuprorelin Acetate Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada Leuprorelin Acetate Sales YoY (2019-2030) & (K Units)
    Figure 20. US & Canada Leuprorelin Acetate Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Leuprorelin Acetate Sales YoY (2019-2030) & (K Units)
    Figure 22. Europe Leuprorelin Acetate Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Leuprorelin Acetate Sales YoY (2019-2030) & (K Units)
    Figure 24. China Leuprorelin Acetate Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) Leuprorelin Acetate Sales YoY (2019-2030) & (K Units)
    Figure 26. Asia (excluding China) Leuprorelin Acetate Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Leuprorelin Acetate Sales YoY (2019-2030) & (K Units)
    Figure 28. Middle East, Africa and Latin America Leuprorelin Acetate Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Leuprorelin Acetate Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of Leuprorelin Acetate in the World: Market Share by Leuprorelin Acetate Revenue in 2023
    Figure 31. Global Leuprorelin Acetate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Leuprorelin Acetate Sales Market Share by Type (2019-2030)
    Figure 33. Global Leuprorelin Acetate Revenue Market Share by Type (2019-2030)
    Figure 34. Global Leuprorelin Acetate Sales Market Share by Application (2019-2030)
    Figure 35. Global Leuprorelin Acetate Revenue Market Share by Application (2019-2030)
    Figure 36. US & Canada Leuprorelin Acetate Sales Market Share by Type (2019-2030)
    Figure 37. US & Canada Leuprorelin Acetate Revenue Market Share by Type (2019-2030)
    Figure 38. US & Canada Leuprorelin Acetate Sales Market Share by Application (2019-2030)
    Figure 39. US & Canada Leuprorelin Acetate Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Leuprorelin Acetate Revenue Share by Country (2019-2030)
    Figure 41. US & Canada Leuprorelin Acetate Sales Share by Country (2019-2030)
    Figure 42. U.S. Leuprorelin Acetate Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada Leuprorelin Acetate Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe Leuprorelin Acetate Sales Market Share by Type (2019-2030)
    Figure 45. Europe Leuprorelin Acetate Revenue Market Share by Type (2019-2030)
    Figure 46. Europe Leuprorelin Acetate Sales Market Share by Application (2019-2030)
    Figure 47. Europe Leuprorelin Acetate Revenue Market Share by Application (2019-2030)
    Figure 48. Europe Leuprorelin Acetate Revenue Share by Country (2019-2030)
    Figure 49. Europe Leuprorelin Acetate Sales Share by Country (2019-2030)
    Figure 50. Germany Leuprorelin Acetate Revenue (2019-2030) & (US$ Million)
    Figure 51. France Leuprorelin Acetate Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. Leuprorelin Acetate Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy Leuprorelin Acetate Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia Leuprorelin Acetate Revenue (2019-2030) & (US$ Million)
    Figure 55. China Leuprorelin Acetate Sales Market Share by Type (2019-2030)
    Figure 56. China Leuprorelin Acetate Revenue Market Share by Type (2019-2030)
    Figure 57. China Leuprorelin Acetate Sales Market Share by Application (2019-2030)
    Figure 58. China Leuprorelin Acetate Revenue Market Share by Application (2019-2030)
    Figure 59. Asia Leuprorelin Acetate Sales Market Share by Type (2019-2030)
    Figure 60. Asia Leuprorelin Acetate Revenue Market Share by Type (2019-2030)
    Figure 61. Asia Leuprorelin Acetate Sales Market Share by Application (2019-2030)
    Figure 62. Asia Leuprorelin Acetate Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Leuprorelin Acetate Revenue Share by Region (2019-2030)
    Figure 64. Asia Leuprorelin Acetate Sales Share by Region (2019-2030)
    Figure 65. Japan Leuprorelin Acetate Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea Leuprorelin Acetate Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan Leuprorelin Acetate Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia Leuprorelin Acetate Revenue (2019-2030) & (US$ Million)
    Figure 69. India Leuprorelin Acetate Revenue (2019-2030) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Leuprorelin Acetate Sales Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Leuprorelin Acetate Revenue Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Leuprorelin Acetate Sales Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Leuprorelin Acetate Revenue Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Leuprorelin Acetate Revenue Share by Country (2019-2030)
    Figure 75. Middle East, Africa and Latin America Leuprorelin Acetate Sales Share by Country (2019-2030)
    Figure 76. Brazil Leuprorelin Acetate Revenue (2019-2030) & (US$ Million)
    Figure 77. Mexico Leuprorelin Acetate Revenue (2019-2030) & (US$ Million)
    Figure 78. Turkey Leuprorelin Acetate Revenue (2019-2030) & (US$ Million)
    Figure 79. Israel Leuprorelin Acetate Revenue (2019-2030) & (US$ Million)
    Figure 80. GCC Countries Leuprorelin Acetate Revenue (2019-2030) & (US$ Million)
    Figure 81. Leuprorelin Acetate Value Chain
    Figure 82. Leuprorelin Acetate Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Leuprorelin Acetate Microspheres for Injection Market Research Report 2024
Global Leuprolide Market Research Report 2024
Global Enanton Leucorin Acetate Market Research Report 2024
Global Leuprorelin Drugs Market Research Report 2024
Global Triptorelin Acetate Market Insights Forecast to 2030
Global Gonadorelin Acetate Market Insights Forecast to 2030
Global GnRHa Peptide Drugs Market Research Report 2024
Global Alarelin Acetate Market Insights Forecast to 2030
Global Zoladex Market Insights Forecast to 2030
Global GnRH Agonist Market Research Report 2024
Global Gonadorelin Market Insights Forecast to 2030
Global Leuprorelin Acetate API Market Research Report 2025
Global Gonadotropin releasing Hormone Antagonists Market Research Report 2024
Global Histrelin Market Insights Forecast to 2030
Global Triptorelin Acetate Microspheres for Injection Market Research Report 2024
Triptorelin Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Goserelin Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nafarelin Market Insights Forecast to 2030
Global GnRH Analogues Market Research Report 2024
Global Goserelin Acetate Sustained Release Implant Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions